Tango Therapeutics (TNGX) Retained Earnings: 2020-2025
Historic Retained Earnings for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to -$564.4 million.
- Tango Therapeutics' Retained Earnings fell 21.67% to -$564.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$564.4 million, marking a year-over-year decrease of 21.67%. This contributed to the annual value of -$501.6 million for FY2024, which is 35.10% down from last year.
- According to the latest figures from Q3 2025, Tango Therapeutics' Retained Earnings is -$564.4 million, which was up 2.74% from -$580.3 million recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Retained Earnings ranged from a high of -$362,800 in Q1 2021 and a low of -$580.3 million during Q2 2025.
- For the 3-year period, Tango Therapeutics' Retained Earnings averaged around -$438.5 million, with its median value being -$434.7 million (2024).
- Data for Tango Therapeutics' Retained Earnings shows a maximum YoY tumbled of 263,397.41% (in 2021) over the last 5 years.
- Over the past 5 years, Tango Therapeutics' Retained Earnings (Quarterly) stood at -$161.3 million in 2021, then tumbled by 67.05% to -$269.5 million in 2022, then crashed by 37.75% to -$371.3 million in 2023, then crashed by 35.10% to -$501.6 million in 2024, then dropped by 21.67% to -$564.4 million in 2025.
- Its last three reported values are -$564.4 million in Q3 2025, -$580.3 million for Q2 2025, and -$541.4 million during Q1 2025.